Maestro MEA Platform Powers First Stem Cell Cardiac Safety Assay in FDA ISTAND ProgramThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Feb 18, 2026– Axion BioSystems today announced that the FDA’s ...